Kahr Medical
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients With Hematological Malignancies (NCT04937166) | Kahr Medical | 2022-01-13 |
| A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors (NCT04440735) | Kahr Medical | 2020-10-07 |
Track Kahr Medical automatically
Every clearance here is in the API, with alerts when new ones post.